Daily Archives: November 10, 2019 | LinksMedicus Free Medical News & Perspectives

#KidneyWk – Randomized Trial: Vitamin D and Omega-3 Fatty Acids Do Not Preserve Kidney Function in Patients with Type 2 Diabetes

10 Nov, 2019 | 14:36h | UTC

Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials – JAMA (free for a limited period)

Commentary: Supplements don’t preserve kidney health in Type 2 diabetes – University of Washington School of Medicine (free)

#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019

Related Commentary on Twitter

Study findings do not support the use of #vitaminD or #omega3 fatty acid supplementation for preserving kidney function in adults with #type2diabetes https://t.co/ppUnvwMXRR #KidneyWk

— JAMA (@JAMA_current) November 9, 2019

#KidneyWk – [Abstract Only] Randomized Trial: New Drug May Reduce Itch Intensity in Hemodialysis Patients

10 Nov, 2019 | 14:34h | UTC

A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Novel Drug Eases Uremic Pruritus – Renal & Urology News (free)

#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019

#KidneyWk – Study: Development of a Risk Prediction Calculator for Incident Chronic Kidney Disease

10 Nov, 2019 | 14:39h | UTC

Development of Risk Prediction Equations for Incident Chronic Kidney Disease – JAMA (free for a limited period)

See Calculator: Risk of Developing Reduced Kidney Function (free tool)

Editorial: Predicting Risk of Kidney Disease: Is Risk-Based Kidney Care on the Horizon? – JAMA (free for a limited period)

Commentaries: New Tool Predicts Five-Year Risk of Chronic Kidney Disease With High Accuracy – Johns Hopkins Bloomberg School of Public Health (free) AND Researchers Develop Tool to Identify Those at Risk of Future CKD – AJMC (free)

#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019

Related Commentary on Twitter

Equations for predicting risk of incident #CKD were developed from more than 5 million individuals from 34 multinational cohorts and demonstrated high discrimination and variable calibration in diverse populations https://t.co/7uNRpv4m3Y #KidneyWk

— JAMA (@JAMA_current) November 8, 2019

CDC: Vaping Lung Illness Probably Caused by Vitamin E Acetate

10 Nov, 2019 | 14:30h | UTC

CDC Reports: Risk Factors for E-Cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products — Illinois, July–October 2019 (free) AND Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019 (free)

Commentaries: In a breakthrough, health officials identify possible culprit behind vaping illnesses: vitamin E acetate – STAT (free) AND Vaping Illnesses Are Linked to Vitamin E Acetate, C.D.C. Says – The New York Times (10 articles per month are free) AND CDC Finds Possible Culprit In Outbreak Of Vaping-Related Lung Injuries – NPR (free)

#KidneyWk – Study: Baclofen Associated with Increased Risk of Encephalopathy in Patients with Chronic Kidney Disease

10 Nov, 2019 | 14:35h | UTC

Association of Baclofen with Encephalopathy in Patients With Chronic Kidney Disease – JAMA (free for a limited period)

Commentary: Common muscle relaxant causes severe confusion in patients with kidney disease – University of Western Ontario (free)

#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019

#KidneyWk – [Not Published Yet] Randomized Trial: Less Expensive Azathioprine as Good as Mycophenolate Mofetil in Kidney Transplant Recipients on Steroid-Free Low-Dose Cyclosporine Immunosuppression

10 Nov, 2019 | 14:33h | UTC

Mycophenolate Mofetil versus Azathioprine in Kidney Transplant Recipients on Steroid-Free Low-Dose Cyclosporine Immunosuppression: The ATHENA Trial – 2019 American Transplant Congress (free)

#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology – 2019

10 Nov, 2019 | 13:59h | UTC

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology – 2019 – Arquivos Brasileiros de Cardiologia (free PDF)

A New Twenty-first Century Science for Effective Epidemic Response

10 Nov, 2019 | 13:41h | UTC

A new twenty-first century science for effective epidemic response – Nature (free for a limited period)

Podcast: Management of Multimorbidity

10 Nov, 2019 | 13:55h | UTC

#181 The Multimorbidity Games with Josh Uy MD – The Curbsiders Internal Medicine Podcast (free text and audio)

FDA Safety Communication: Biotin Supplements May Result in Falsely Low Troponin Results

10 Nov, 2019 | 13:43h | UTC

UPDATE: The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication – U.S Food and Drug Administration (free)

Commentary: FDA Updates Warning on Biotin Interfering with Lab Results – NEJM Journal Watch (free)

“…the FDA is particularly concerned about biotin interference causing a falsely low result for troponin, a clinically important biomarker to aid in the diagnosis of heart attacks, which may lead to a missed diagnosis and potentially serious clinical implications. The FDA continues to receive adverse events reports indicating biotin interference caused falsely low troponin results.”